Skip to main content
Premium Trial:

Request an Annual Quote

Lucigen Becomes Sole Distributor for Illumina Epicentre Products

NEW YORK (GenomeWeb) –Lucigen said today that it has signed a global agreement with Illumina for Lucigen to be the sole distributor of Epicentre Technologies' genomics kits, enzymes, and ancillary reagents.

Products covered by the new agreement are in addition to select Epicentre products that were licensed and transferred to Lucigen for manufacture and distribution in December, the company said.

Lucigen, based in Madison, Wisconsin, manufactures and supplies products for synthetic biology, next-generation sequencing, genetic amplification, and protein expression research.

Epicentre was acquired by Illumina in 2011, and is known for its genomics and transcriptomics products for gene expression, cloning, and in vitro transcription.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.